SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-777415
Filing Date
2016-11-28
Accepted
2016-11-28 07:20:03
Documents
9
Period of Report
2016-11-28
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d288858d8k.htm 8-K 15396
2 EX-99.1 d288858dex991.htm EX-99.1 16505
3 EX-99.2 d288858dex992.htm EX-99.2 28793
4 GRAPHIC g288858ex99_2s1gbgd.jpg GRAPHIC 14508
5 GRAPHIC g288858ex99_2s2gbgd.jpg GRAPHIC 14508
6 GRAPHIC g288858ex99_2s3gbgd.jpg GRAPHIC 30757
7 GRAPHIC g288858ex99_2s4gbgd.jpg GRAPHIC 16425
8 GRAPHIC g288858ex99_2s5gbgd.jpg GRAPHIC 18032
9 GRAPHIC g288858img1.jpg GRAPHIC 15823
  Complete submission text file 0001193125-16-777415.txt   214026
Mailing Address 490 LAPP ROAD MALVERN PA 19355
Business Address 490 LAPP ROAD MALVERN PA 19355 (484) 395-2400
Recro Pharma, Inc. (Filer) CIK: 0001588972 (see all company filings)

IRS No.: 261523233 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36329 | Film No.: 162018573
SIC: 2834 Pharmaceutical Preparations